An evaluation of a hybrid compact gamma camera to simplify the sentinel node procedure in breast cancer.
Completed
- Conditions
- Lymph NodeSentinel node10006291
- Registration Number
- NL-OMON42201
- Lead Sponsor
- Antoni van Leeuwenhoek Ziekenhuis
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 56
Inclusion Criteria
- Woman
- Proven breast cancer
- Scheduled for SN procedure
- De patient must be able to provide *informed consent*
Exclusion Criteria
Other radionuclides which could influence the procedure. (This does not apply for a ROLL procedure with Tc-99m MAA or Nanocolloid or an I-125 seed)
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>The primary outcome criterion is the difference in detection rate between<br /><br>planar scintigraphy and the hybrid GCG. </p><br>
- Secondary Outcome Measures
Name Time Method <p>- The incremental value of the hybrid CGC in assisting in surgery for SN<br /><br>detection next to the gamma probe.<br /><br>- A subjective outcome describing the additional value of the hybrid aspect of<br /><br>this camera.<br /><br>- The feasibility to localise I-125 seeds in breast cancer surgery. </p><br>
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular imaging techniques enable the hybrid compact gamma camera to detect sentinel lymph nodes in breast cancer?
How does the hybrid gamma camera compare to traditional SPECT/CT in sentinel node localization accuracy for early-stage breast cancer?
Which biomarkers correlate with successful sentinel node identification using the hybrid gamma camera in HER2-negative breast cancer patients?
What adverse events are reported with the hybrid gamma camera during sentinel node procedures versus conventional radioactive tracers in breast cancer?
Are there alternative radiopharmaceuticals or imaging systems being evaluated for sentinel node detection in breast cancer alongside the hybrid gamma camera?